WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · LC 2896

Legislative bill overview

LC 2896 would authorize schools in Montana to maintain and administer emergency albuterol inhalers to students experiencing acute asthma symptoms, regardless of whether the student has a prior prescription. This legislation aims to provide immediate respiratory relief in life-threatening asthma emergencies when a student's personal inhaler is unavailable or when symptoms arise unexpectedly.

Why is this important

Asthma is a common chronic condition among school-age children, and severe asthma attacks can be fatal if untreated. Authorizing schools to administer emergency albuterol could reduce response time during critical respiratory events and potentially save lives, while also addressing situations where students lack access to their prescribed medications during school hours.

Potential points of contention

  • Liability concerns: Schools may resist due to fears of legal liability if a student has an adverse reaction to emergency albuterol administration, even when acting in good faith
  • Medical authorization requirements: Debate over whether standing orders from physicians or school health officers should be required, versus allowing schools broader discretion
  • Implementation costs: Expenses for training staff, maintaining medication supplies, and establishing protocols could strain school budgets
  • Parental notification and consent: Questions about whether prior parental consent is needed versus emergency administration authority during acute situations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.